Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
#Therapeutic Drug Monitoring Market Forecast: What Value Will The Market Reach By 2030?#_x000D_
The therapeutic drug monitoring market has seen substantial expansion in recent years. Its valuation is anticipated to climb from $2.41 billion in 2025 to $2.67 billion in 2026, showing a compound annual growth rate (CAGR) of 10.9%. This past growth is largely due to the increasing utilization of narrow therapeutic index drugs, the expansion of hospital laboratory testing capabilities, the widespread adoption of immunoassay technologies, a rise in the occurrence of chronic diseases, and enhancements in analytical instrumentation._x000D_
_x000D_
The therapeutic drug monitoring market is anticipated to experience substantial expansion in the coming years. Its valuation is projected to reach $4.09 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.2%. This projected growth throughout the forecast period stems from factors such as the increasing need for precision medicine, the proliferation of automated diagnostic laboratories, a heightened emphasis on patient-specific dosing, progress in mass spectrometry technologies, and the rising uptake of real-time therapeutic monitoring. Significant trends during this period encompass the wider acceptance of LC-MS based monitoring methods, the increasing application of personalized medicine strategies, the broader integration of automated laboratory systems, an expansion in real-time drug level analysis, and a sharpened focus on precision dosing._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Therapeutic Drug Monitoring Market Growth Backed By Core Demand Fundamentals#_x000D_
The therapeutic drug monitoring market is projected to grow as drug consumption escalates. Drugs are substances administered for medical purposes to diagnose, treat, or prevent ailments in humans or animals. Therapeutic drug monitoring is utilized to refine drug dosage regimens by quantifying and adjusting drug concentrations within the bloodstream, thereby ensuring therapeutic effectiveness and minimizing adverse effects. For instance, in January 2024, the Office for Health Improvement & Disparities, a UK government department, reported that between April 2022 and March 2023, a total of 12,418 young people under 18 accessed alcohol and drug services, which signifies a 10% increase from the 11,326 cases observed in the preceding year. This escalating use of drugs is consequently propelling the therapeutic drug monitoring market._x000D_
_x000D_
#Therapeutic Drug Monitoring Market Segment Trends And Revenue Contributors#_x000D_
The therapeutic drug monitoring market covered in this report is segmented – _x000D_
_x000D_
1) By Product: Consumables, Equipment, Immunoassay Analyzers, Chromatography And Detectors_x000D_
2) By Class Of Drug: Antiepileptic Drugs, Antibiotic Drugs, Immunosuppressant Drugs, Antiarrhythmic Drugs, Psychoactive Drugs, Other Drugs_x000D_
3) By End-user: Hospital Laboratories, Commercial and Private Laboratories, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Consumables: Reagents, Test Kits, Sample Collection Containers, Calibration Standards_x000D_
2) By Equipment: Analyzers, Incubators, Centrifuges_x000D_
3) By Immunoassay Analyzers: ELISA Analyzers, Chemiluminescent Immunoassay Analyzers, Radioimmunoassay Analyzers_x000D_
4) By Chromatography And Detectors: High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), Mass Spectrometry (MS)_x000D_
_x000D_
_x000D_
#Therapeutic Drug Monitoring Market Growth Trends Reshaping The Competitive Landscape#_x000D_
Leading companies in the therapeutic drug monitoring market are prioritizing the development of anti-idiotypic antibody technology to improve the sensitivity and specificity of assays used for precisely measuring biologic drug levels and evaluating patient immune responses. This anti-idiotypic antibody technology supports therapeutic drug monitoring by enabling exact detection and quantification of biologic drug levels, thereby ensuring accurate dosing and monitoring of patient immune reactions. For example, in June 2024, Bio-Rad Laboratories, a US-based biotechnology company, introduced new anti-idiotypic and anti-monomethyl auristatin E (MMAE) antibodies designed for bioanalytical assays, which enhances pharmacokinetic (PK) and antidrug-antibody (ADA) monitoring. These innovative antibodies increase the reliability of assays for antibody-drug conjugates (ADCs) and are essential for the therapeutic drug monitoring market, facilitating precise evaluations of drug concentrations and immune responses for optimal patient treatment._x000D_
_x000D_
#Therapeutic Drug Monitoring Market Competitive Landscape: Which Companies Lead The Industry?#_x000D_
Major companies operating in the therapeutic drug monitoring market are Abbott Laboratories Inc., F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Sekisui Medical Co., Buehlmann Laboratories AG, Danaher Corporation, Bio-Rad Laboratories Inc., bioMérieux SA, Randox Laboratories Limited, Chromsystems Instruments & Chemicals GmbH, Grifols SA, Merck KGaA, BioChem Pharmaceuticals, Beckman Coulter Inc., DiaSorin S.p.A., Hologic Inc., Immunodiagnostic Systems Holdings plc, Kronus Inc., QuidelOrtho Corporation, Sysmex Corporation, TDM Solutions Inc., Theradiag, Tosoh Bioscience LLC, Trinity Biotech plc, Associated Regional and University Pathologists Inc., Mayo Clinic Laboratories, Quest Diagnostics _x000D_
_x000D_
#View The Full Therapeutic Drug Monitoring Market Report:#_x000D_
_x000D_
#Therapeutic Drug Monitoring Market Regional Outlook: Where Is Opportunity Concentrated?#_x000D_
North America was the largest region in the therapeutic drug monitoring market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global therapeutic drug monitoring market report during the forecast period. The regions covered in the therapeutic drug monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.